Tianwu Tech Pioneers AI-Driven Protein Design, Unlocking New Opportunities in IVD Upstream Innovation

After all, AI technology is just a new technology. If it does not show great application potential, then it is ultimately just a general-purpose technology. Its application in the field of proteins is thanks to AlphaFold. However, as mentioned above, it only...Solved the problem of protein design from sequence to structure, but it is already a great progress, accelerating human exploration and research in biology.

This represents significant progress compared to previous design methods that relied on the experience of professional researchers, complex computational processes, and subsequent testing of protein functions, laying a foundation for solving the problem of structure-to-function. Subsequently, with the development of the times,AI technology, like the Polaris, has officially debuted. Matwings Technology has accordingly developed protein design products based on pre-training.Breaking the many pain points of traditional protein engineering methods, such as numerous experiments, long duration, and high costs, has shocked the industry.

Taking advantage of this momentum, since its establishment, Matwings Technology has assisted over 30 enterprises across various industries in reducing production costs, shortening development cycles, and enhancing product performance, earning widespread market recognition. Perhaps it is due to the positive achievements over these three years that...Matwings TechnologyAmidst the current capital winter, securing an A-round financing of over 100 million yuan,The capital market certainly focuses on profitability, emphasizing the project's profit potential, as they wouldn't engage in a losing business.。

And for today's development achievements, Matwings Technology, which has only been established for three years, should be considered a miracle in the industry. Generally speaking, it is traditionally believed that academics turned entrepreneurs need at least 10 years to succeed, which is of course due to established mindsets and conditions.The significance of AI is also reflected here, which can be considered a细分赛道 in the new era, allowing academic talents to have lower entrepreneurial costs. With technology as the starting point, it has the potential to become the best entrepreneurial case in history.

Matwings Technology's protein-related general large model is not just talk, butReliable and versatile, it can be applied not only in the biopharmaceutical fields such as IVD, antibodies, and vaccines, but also in non-biopharmaceutical sectors like beverages, skincare, and agriculture, with a very wide range of applications., Matwings Technology has recently attracted attention from the IVD and biopharmaceutical industries, and it is expected to be applied in more fields in the future. This is logically sound.

Moreover, it is worth mentioning that according to the description of its founder, we can see that the markets created by AI + protein are all incremental. The existing stock competition markets are somewhat inferior in dimension, and...AI + Protein Already Has an Impact on Existing Stock MarketsSiphon Effect, The reason is very simple: it has lower costs and higher efficiency.

Matwings Technology, which successfully completed its first round of financing in 2022, has embarked on large AI protein models. In just a few years, it has delivered more than thirty protein design projects, established strategic partnerships with numerous enterprises, and demonstrated the limitless potential of AI + protein. Using the AccelProtein™ large model, combined with subsequent experimental validation, it is possible to design almost all types of protein sequences. Moreover, the optimization of key indicators such as protein stability, activity, and affinity has reached or even surpassed world-leading levels. Additionally, the time required for optimizing protein properties can be drastically reduced from the traditional 2-5 years to 2-6 months.The progress is of great significance and has been called by some industry insiders as theChatGPT。

Previously, Matwings Technology, in a joint announcement with Jin Sai, successfully completed the development of the world’s first protein product designed by a large model that has entered 5,000-liter scale-up production and practical application. Over the past year, the alkaline resistance of ordinary non-alkali-resistant single-domain antibodies has been increased fourfold, making low-cost purification using affinity chromatography a reality, no longer a distant goal. This is the tremendous productivity of the biological equivalent of ChatGPT.

This all-encompassing capability, starting from the first round in 2022, to the Pre-A round in 2023, and now the A round, has already shown in the hundreds of millions of financing over just three years that the capital market values its enhanced independent R&D capabilities and the profits brought by rapid market expansion. And Matwings Technology is highly likely to achieve this.

The AI-based protein design platform not only pioneers an innovative model but also serves as an effective new quality productive force. Currently, Matwings Technology starts by focusing on the biopharmaceutical industry, providing cost-effective development tools to boost the upstream enterprises' development momentum. Besides producing the proteins originally needed, it can even directly design entirely new proteins that do not exist in nature according to specific requirements, or redesign new protein structures retaining only the functional sites. Over time, its applications will inevitably extend to other fields.

Moreover, in the understanding of new quality productivity, it is relying on AccelProtein™ for enzyme modification, enzyme mining, and enzyme...Catalytic ProcessDeveloping to address the challenges of precise synthesis of high-value molecules that are difficult to solve through chemical synthesis or natural extraction, providing efficient and green AI enzyme catalysis solutions for fields such as pharmaceutical intermediates, fragrances, health product ingredients, and cosmetic raw materials.

References:

1.Official website, related information, ArteryNet

2. Matwings Technology Completes Over 100 Million Yuan in Series A Financing: Mainly Used for AccelProtein Upgrade, Zhongzhi Meihui, 2024